Junshi Biosciences Announces 2021 Interim Financial Results and Provides Corporate Updates

SHANGHAI, China, Aug. 31, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the six months ended June 30, 2021 and provided corporate updates. First Half 2021 Financial Highlights Total revenue reached RMB 2,114 […]

Zoom Reports Financial Results for the Second Quarter of Fiscal Year 2022

Second quarter total revenue of $1,021.5 million, up 54% year over year Number of customers contributing more than $100,000 in TTM revenue up 131% year over year Second quarter GAAP operating margin of 28.8% and non-GAAP operating margin of 41.6% SAN JOSE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) […]